
Elon Musk’s Neuralink Receives FDA Approval for Vision Restoration Implant: What’s Next?
Elon Musk’s brain-implant company, Neuralink, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting “breakthrough device” designation to its experimental vision-restoring implant, Blindsight. This designation is reserved for medical devices that offer potential treatments for life-threatening or irreversibly debilitating conditions, expediting their development and review processes. Blindsight: A New Horizon…